期刊文献+

外周血hTERT mRNA表达与进展期结直肠癌术后复发及预后的关系 被引量:4

Correlation between quantitative detection of hTERT mRNA in peripheral blood and postoperative recurrence and prognosis in patients with advanced colorectal cancer
原文传递
导出
摘要 目的 探讨进展期结直肠癌(CRC)患者外周血人端粒酶逆转录酶(hTERT) mRNA表达量与术后复发及预后的关系.方法 以实时荧光定量RT-PCR定量检测85例进展期CRC患者根治术前、术后1个月及30例健康对照者外周血hTERT mRNA表达量;术后随访3年,CRC复发患者及未复发患者复查外周血hTERT mRNA表达量.结果进展期CRC组术前外周血hTERT mRNA表达量显著高于正常对照组[(6.22 ±5.85)2-△△Ct vs (0.45 ±0.27)2-△△Ct,P <0.01],术后1个月外周血hTERT mRNA表达量显著降低(P<0.01).术后复发组外周血hTERT mRNA表达量显著高于术后1个月组和未复发组[(5.07 ±2.87)2-△△Ctvs(1.83±1.08)2-△△Ct,(2.15 ±1.49)2-△△Ct,(P<0.01)].单因素分析显示肿瘤分化程度、肿瘤大小、淋巴结转移率及有无肝转移是影响进展期CRC患者术前外周血hTERT mRNA表达水平升高的因素(P<0.05或P< 0.01).Logistic多因素回归分析显示肿瘤分化程度、淋巴结转移及肝转移为影响进展期CRC术前外周血hTERT mRNA表达升高的独立危险因素;随着术前外周血hTERT mRNA表达量的升高,CRC患者术后3年复发率逐步升高,术后生存率逐步降低.结论术前外周血hTERTmRNA表达量与进展期CRC重要病理特征相关,是影响预后的重要因素,可作为预后评价指标;术后外周血hTERT mRNA表达量升高与术后复发相关. Objective To investigate the correlation between expression of human telomerase reverse transcriptase (hTERT) mRNA in peripheral blood and postoperative recurrence and prognosis in the patients with advanced colorectal cancer (CRC).Methods The preoperative and 1 month postoperative quantitative expression of hTERT mRNA in peripheral blood in 85 patients with advanced CRC were detected with real-time fluorescence quantitative real-time fluorescence quantitative polymerase chain reaction (RTPCR).The quantitative expression of hTERT mRNA in peripheral blood in 30 normal controls were also detected.The postoperative prognosis was followed-up,and the quantitative expression of hTERT mRNA in peripheral blood in the patients with recurred CRC and the patients without recurred CRC were detected repeatedly.The factors that affected the preoperative hTERT mRNA expression were analyzed.The relationship was investigated between the hTERT mRNA expression levels and postoperative recurrence and prognosis in the patients with advanced CRC.Results The hTERT mRNA expression levels in peripheral blood in advanced CRC group were significantly higher than those in the normal controls [(6.22 ±5.85)2-△△Ct vs (0.45 ±0.27)2-△△Ct,(P 〈0.01)],and were significantly decreased at the time point of 1 month after the operation (P 〈 0.01).The hTERT mRNA expression levels in the postoperative recurred CRC group were significantly higher than those in the 1 month postoperation group and no recurrence CRC group [(5.07 ± 2.87)2-△△Ct vs (1.83 ± 1.08)2-△△Ct,(2.15 ± 1.49)2-△△Ct,(P 〈0.01)].Univariate analysis revealed that preoperative high hTERT mRNA expression levels in peripheral blood were related to the differentiated degree of tumor,tumor size,lymph node metastasis ratio,and liver metastasis (P 〈 0.05 or P 〈 0.01).Multivariate logistic regression analysis revealed that differentiated degree of the tumor,lymph node metastasis,and liver metastasis were independent risk factors for the elevation of preoperative hTERT mRNA expression in the advanced CRC.Elevated preoperative hTERT mRNA expression was positively related to the postoperative recurrence rate,and was negatively related to postoperative survival rate.Conclusions Preoperative hTERT mRNA expression levels in peripheral blood were related to the important pathologic features in patients with advanced CRC,and might be a valuable prognostic factor.Postoperatively elevated hTERT mRNA expression in peripheral blood was related to recurrence of advanced CRC.
出处 《中国医师杂志》 CAS 2014年第5期597-600,604,共5页 Journal of Chinese Physician
基金 湖北省自然科学基金(2010CDB07401),湖北省黄石市医药卫生科研项目(2010-04)
关键词 端粒 末端转移酶 遗传学 RNA 信使 遗传学 端粒 末端转移酶 血液 结直肠肿瘤 外科学 结直肠肿瘤 血液 逆转录聚合酶链反应 复发 预后 Telomerase/genetics RNA, messenger/genetics Telomerase/blood Colorectal neoplasms/surgery Colorectal Neoplasms/blood Reverse transcriptase polymerase chain reaction Recurrence Prognosis
  • 相关文献

参考文献9

  • 1陈琳,侯梅,吴琦,谢可.结直肠癌组织P53、TopoⅡ、VEGF的表达及临床意义[J].中国基层医药,2011,18(18):2547-2548. 被引量:3
  • 2郝志明,罗金燕,程晋,王全颖,杨广笑.人端粒酶逆转录酶第16外显子的克隆[J].中国现代医学杂志,2003,13(2):1-3. 被引量:3
  • 3Simsek BC, Pehtivan S, Karaoglu A. Human telomerase reverse lranscriptase expression in colorectal tumors:correlations with im- munohistochemical expression and clinicopathologic features [ J ]. Ann Diagn Pathol,2010,14(6):413-417.
  • 4Wang JD, Ma J, Wang FY, et al. Amplification of the tetomerase RNA component gcne as a new genetic marker for disease progTes- sion amt prognosis in esophageal squamous cell carcinoma[ J ]. Dis Esophagus,2013,26(7) :737-745.
  • 5Sakabe R, Murakami Y, Uemura K, et al. Prognostic significance of telomerase activity and human telomerase reverse transeriptase expression in ampullary carcinoma[ J]. Ann Surg 0ncot,2012,19 ( 9 ) : 3072 -3080.
  • 6Zhang Y, Toh L, Lau P, et al. Human telomerase reverse tran- scriptase (hTERT) is a novel target of the Wnt/13-catenin pathway in human cancer [ J ]. J Biol Chem, 2012,287 ( 39 ) : 32494- 32511.
  • 7Wellenhofer A, Bmstmann H. Expression of human telomerase re- verse transcriptase in vulvar intraepithelial neoplasia and squamous cell carcinoma: an study with survivin andp53[J]. Arch Pathol Lab Med, 2012,136(11) :1359-1365.
  • 8Mium N, Osaki Y, Nagashima M, et al. A novel biomarker TERT mRNA is applicable for early detection of hepatoma [ J ]. BMC Gastmentem1,2010,10:46.
  • 9Pofika M, Tippani R, Mohammad A, et al. Evaluation of serum human telomerase reverse transeriptase as a novel marker for cervi- cal cancer[ J]. Int J Biol Markers,2011,26( 1 ) :22-26.

二级参考文献17

  • 1刘鹏,张桂英,李艳春,钟仁华.PTEN、p53和PCNA在大肠癌组织的表达及临床意义[J].医学临床研究,2005,22(9):1227-1229. 被引量:10
  • 2彭亦良,梁后杰,高晋华,王伟中,李焱,边志衡.结肠癌组织中VEGF-C和VEGFR-3表达与淋巴管生成及淋巴结转移的关系[J].中国肿瘤临床与康复,2006,13(1):1-3. 被引量:1
  • 3郭威,宋光,吴国新,杨淑梅.GST-π、P-gp及Topo Ⅱ在大肠癌中的表达及其多药耐药的临床研究[J].齐齐哈尔医学院学报,2007,28(3):269-272. 被引量:6
  • 4[1]Harley CB. Telomere loss: Mitotic clock or genetic time tomb? Murat Res,1991:256:271~282
  • 5[2]de Lange T. Activation of telomerase in a human tumor. Proc Natl Acaad Sci USA,1994;91:2882~2885
  • 6[3]Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science, 1994; 266:2011~2015
  • 7[4]Dhaene K, van Marck E, Parwaresch R. Telomeres, telomerase and cancer: an update. Virchows Arch, 2000;437:1~16
  • 8[6]Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science, 1997;277:955~959
  • 9[7]Wick M, Zubov D, Hagen G. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene, 1999; 232:97~106
  • 10[8]Wickens M, Bernstein DS, Kimble J, Parker R. A PUF family portrait: 3'UTR regulation as a way of life. Trends Genet, 2002;18(3):150~157

共引文献4

同被引文献51

  • 1Zhang D,Yu M,Xu T,et al. Predictive value of serum CEA,CA19-9 and CA125 in diagnosis of colorectal liver metastasis inChinese population [ J ]. Hepatogastroenterology, 2013,60(126):1297-1301.
  • 2Simsek BC,Pehlivan S,Karaoglu A. Human telomerasereverse transcriptase expression in colorectal tumors:correlations with immunohistochemical expression andclinicopathologic features[J]. Ann Diagn Pathol,2010,14(6):413-417.
  • 3Zhang Y,Toh L,Lau P,et al. Human telomerase reversetranscriptase (hTERT) is a novel target of the Wnt/j3-cateninpathway in human cancer[J]. J Biol Chem, 2012 , 287 ( 39):32494-32511.
  • 4Hong B,Zu Y. Detecting circulating tumor cells: currentchallenges and new trends [ J]. Theranostics, 2013,3 (6):377-394.
  • 5Lu CY, Tsai HL, Uen YH, et al. Circulating tumor cells as asurrogate marker for determining clinical outcome tomFOLFOX chemotherapy in patients with stage HI coloncancer[J]. Br J Cancer,2013 ,108(4) : 791-797.
  • 6Miura N,Osaki Y, Nagashima M, et al. A novel biomarkerTERT mRNA is applicable for early detection of hepatoma[J/OL]. BMC Gastroenterol, 2010,10 : 46 [2010-05-18]. http://www. biomedcentral. com/1471-230X/10146.
  • 7Wang L,Yao M, Dong Z, et al. Circulating specificbiomarkers in diagnosis of hepatocellular carcinoma and itsmetastasis monitoring[J]. Tumour Biol,2014,35(1) :9-20.
  • 8Porika M, Tippani R, Mohammad A, et al. Evaluation ofserum human telomerase reverse transcriptase as a novelmarker for cervical cancer [J]. Int J Biol Markers, 2011,26(l):22-26.
  • 9Wang JD, Ma J,Wang FY, et al. Amplification of thetelomerase RNA component gene as a new genetic marker fordisease progression and prognosis in esophageal squamous cellcarcinoma[J]. Dis Esophagus, 2013 ,26C7) : 737-745.
  • 10March-Villalba JA, Martinez-Jabaloyas JM, Herrero MJ, etal. Cell-free circulating plasma hTERT mRNA is a usefulmarker for prostate cancer diagnosis and is associated withpoor prognosis tumor characteristics[J/OL]. PLoS One,2012,7(8) : e43470[2012-08-20]. http: // www. plosone. org/article/info % 3 Adoi 2 FI 0. 1371 ^2Fjournal. pone. 0043470.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部